The distribution landscape of the US dry eye syndrome market is evolving rapidly, driven by increasing patient awareness, innovative treatment options, and a growing diagnosis rate. As we move towards 2024, the market size is projected at $1.085 billion, with a CAGR of 5.33% leading to an anticipated $1.922 billion by 2035. This growth is propelled by an expanding patient base actively seeking...